Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.

Published Date: 14 Jun 2023

LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells lacking in DNA damage repair, according to a recent study that appeared in Oncotarget.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Beyond What Is Visible in Myelofibrosis?

2.

The risk of cancer is decreased by following international health recommendations.

3.

Chemotherapy can be a challenging treatment?here's how to deal with some of the side-effects

4.

Cancer Patients' Depression May Be Helped by Psilocybin.

5.

Basal stem-like cells identified as origin of small cell lung cancer in lab models


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot